A clinical study to investigate the efficacy of BioElectronic's RecoveryRx device for postoperative pain management and recovery after total knee arthroplasty surgery has begun.
Here are four things to know.
1. The clinical study will include 40 subjects who are already scheduled for TKR surgery. Each subject will be randomly assigned to receive an active or placebo device.
2. Study enrollment has begun, and the study is set to finish December 2018.
3. The study is being conducted at the New Mazloum Hospital in Tripoli, Lebanon. BioElectronic's distributor in Lebanon, Dr. Omar Tabbouche, is managing the study and introducing BioElectronics' devices into the Lebanese marketplace.
4. The study will help RecoveryRx gain regulatory clearance, according to Ian Rawe, PhD, director of clinical research at BioElectronics.
Here is more information on the study.
More articles on orthopedics:
Orthopedic surgeon to know: Dr. David Dalury of Towson Orthopaedic Associates